Home / Import refusals / NUV-3852229-1/270002/1

NUV-3852229-1/270002/1

Bristol-Myers Squibb Company — FEI 3008455069

Recent inspections

  • 1272436 (VAI Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1115960 (VAI Fri Jan 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1008167 (VAI Wed Apr 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 932048 (NAI Fri Jun 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 836877 (VAI Thu Jun 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • NUV-3881703-0/30002/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3881703-0/60002/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3881703-0/20002/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3881703-0/40002/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3881703-0/10002/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

Refusal Details

Date
November 4, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
61LCA44 APIXABAN (ANTI-COAGULANT)
Charges
179